Literature DB >> 29122222

Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.

J Ye1, X Xie2, Y Lin3, B Liu1, W Wang1, X Huang1, G Huang4.   

Abstract

AIM: To evaluate the relationship between the imaging features of combined hepatocellular-cholangiocarcinoma (CHC) on contrast-enhanced ultrasound (CEUS) and clinicopathological findings.
MATERIALS AND METHODS: From August 2004 to August 2016, 40 patients (29 males, 11 females; mean age 52.8±11.2 years) with histopathologically proven CHC were investigated. The CEUS imaging features and clinicopathological findings of CHC were analysed and compared retrospectively.
RESULTS: On CEUS, peripheral irregular rim-like enhancement, diffuse heterogeneous enhancement, and diffuse homogeneous enhancement was illustrated in 13 (32.5%), 21 (52.5%), and six (15%) lesions, respectively. Histopathological findings showed hepatocellular carcinoma (HCC) predominance and cholangiocarcinoma (CC) predominance throughout the tumour were illustrated in 21 (52.5%) and 19 (47.5%) cases, respectively. HCC-predominant CHCs displayed diffuse heterogeneous enhancement more frequently than peripheral irregular rim-like enhancement (p=0.005), whereas CC-predominant CHCs displayed peripheral irregular rim-like enhancement more frequently than diffuse heterogeneous enhancement and homogeneous enhancement (p=0.005 and p=0.01, respectively). CHCs >5 cm displayed diffuse heterogeneous enhancement more frequently than diffuse homogeneous enhancement, whereas CHCs ≤5 cm displayed diffuse homogeneous enhancement more frequently than diffuse heterogeneous enhancement (p=0.004).
CONCLUSION: The enhancement pattern of CHC on CEUS depended on the relative proportions of the HCC and CC components and showed size-dependent characteristics.
Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29122222     DOI: 10.1016/j.crad.2017.10.003

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma.

Authors:  Yan Zhou; Shanshan Yin; Lin Zhao; Xiang Zhang; Meng Li; Jianmin Ding; Kun Yan; Xiang Jing
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.

Authors:  Takamichi Ishii; Takashi Ito; Shinji Sumiyoshi; Satoshi Ogiso; Ken Fukumitsu; Satoru Seo; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg Oncol       Date:  2020-12-04       Impact factor: 2.754

3.  Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators.

Authors:  Yanling Chen; Qing Lu; Weibin Zhang; Jiaying Cao; Yi Dong; Wenping Wang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

4.  Evaluation of Cardiac Space-Occupying Lesions by Myocardial Contrast Echocardiography and Transesophageal Echocardiography.

Authors:  Mingming Ren; Lei Huang; Xiaoqiang Ye; Zhifeng Xv; Chun Ouyang; Zhen Han
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

5.  Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound.

Authors:  Wei Jiang; Xiaofei Deng; Ting Zhu; Yuya Wei; Zhen Lei; Meimei Guo; Jiong Yang
Journal:  Cancer Manag Res       Date:  2020-03-12       Impact factor: 3.989

6.  Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning.

Authors:  Jun Zhang; Zixing Huang; Likun Cao; Zhen Zhang; Yi Wei; Xin Zhang; Bin Song
Journal:  Ann Transl Med       Date:  2020-02

7.  Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver.

Authors:  Peihua Wang; Fang Nie; Tiantian Dong; Dan Yang; Ting Liu; Guojuan Wang
Journal:  Diagnostics (Basel)       Date:  2021-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.